Other specific arthropathies

M13_OTERSPECARTHR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M12.8 Hospital discharge: ICD-9 — 7164 Cause of death: ICD-10 — M12.8 Cause of death: ICD-9 — 7164 2 out of 7 registries used, show all original rules.	80
4. Check minimum number of events None	80
5. Include endpoints None	80
6. Filter based on genotype QC (FinnGen only)	72

Control definitions (FinnGen only)

Control exclude: M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M12
Name in latin: Aliae arthropathiae specificae non alibi classificatae

NAME	M13_OTERSPECARTHR
CONTROL_EXCLUDE	M13_ARTHROPATHIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M128
HD_ICD_9	7164
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M128
COD_ICD_9	7164
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specific arthropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	538	264	268
Only index persons	487	239	248
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	43.11	48.62	37.31
Only index persons	39.19	46.04	32.59

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	72	41	31
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	49.25	51.96	45.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
74: Matched controls
740

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M12.8

ICD-10 Finland

Other specific arthropathies, not elsewhere classified

+∞

75.4

7164A

ICD-9 Finland

Other and unspecified arthropathies, Transient arthropathy

+∞

16.2

M19.0

ICD-10 Finland

Primary arthrosis of other joints

38.8

14.7

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

21.9

14.5

M13.9

ICD-10 Finland

Arthritis, unspecified

61.7

13.4

L04AX03

ATC

methotrexate; systemic

19.3

12.1

A07EC01

ATC

sulfasalazine; oral, rectal

26.3

11.2

M25.5

ICD-10 Finland

Pain in joint

5.3

11.0

P01BA02

ATC

hydroxychloroquine; oral

28.2

10.7

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

+∞

10.7

M17.1

ICD-10 Finland

Other primary gonarthrosis

20.5

10.4

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

31.0

10.2

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

57.0

8.9

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

57.0

8.9

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

15.3

8.8

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

31.8

8.8

L01BA01

ATC

methotrexate; systemic

101.1

8.6

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

+∞

8.5

M16.1

ICD-10 Finland

Other primary coxarthrosis

38.0

8.3

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

+∞

7.4

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

+∞

7.4

L88

ICPC

Rheumatoid/seropositive arthritis

44.2

6.9

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

10.8

6.6

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

76.1

6.5

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

76.1

6.5

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

+∞

6.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

+∞

6.3

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

6.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

9.3

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4.63

8.76

1.4

1.2

25.26

1.18

u/ml

—

(3037522) Nuclear Ab [Titer] in Serum

4.98

8.76

1.6

1.3

440.00

351.11

titre

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4.10

7.33

1.4

1.2

16.37

13.81

iu/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

17.67

5.54

1.1

1.0

—

(3017732) Neutrophils [#/volume] in Blood

3.32

4.01

1.8

4.2

4.29

4.98

e9/l

0.59

(36660697) Celiac disease serology panel - Serum

3.43

3.83

1.1

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

5.86

3.64

1.1

0.26

0.27

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

5.53

3.49

1.1

1.26

1.25

g/l

—

(3015736) pH of Urine

258

2.20

2.77

2.9

5.92

6.19

0.88

149

(3003327) Ova and parasites identified in Stool by Light microscopy

4.58

2.76

2.8

1.6

—

(3049717) Cytology report of Urine Cyto stain

4.58

2.76

2.1

2.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.03

2.66

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

420

2.37

2.60

6.1

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

228

2.13

2.56

2.8

3.4

22.00

55.91

ng/l

1.23

156

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3.45

2.55

7.5

4.2

1.98

1.18

mmol/l

—

(42870588) Differential panel, method unspecified - Blood

198

2.09

2.38

10.8

4.7

—

(3035350) Ketones [Presence] in Urine by Test strip

338

2.07

2.30

3.6

3.3

0.00

estimate

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

4.56

2.20

1.3

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

139

2.08

2.09

3.6

3.1

—

(3008898) HLA-B27 [Presence]

4.25

2.08

1.3

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

339

1.94

1.99

3.7

3.3

0.00

estimate

—

(3002030) Lymphocytes/Leukocytes in Blood

292

1.91

1.95

11.2

5.3

25.62

27.87

0.66

279

(3021601) Nitrite [Presence] in Urine by Test strip

333

1.90

1.88

3.8

3.2

0.00

estimate

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.74

1.88

1.2

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

4.38

1.85

1.0

1.4

—

(3022313) Gas panel - Capillary blood

2.86

1.78

6.5

4.0

—

(3032080) INR in Blood by Coagulation assay

270

1.84

1.77

10.6

12.3

1.19

1.24

inr

0.24

226

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

253

1.82

1.73

3.4

3.1

0.00

estimate

—

(3021960) Folate [Moles/volume] in Serum or Plasma

167

1.86

1.65

1.9

1.6

19.47

20.30

nmol/l

0.11

140

(40758558) Short blood count panel - Blood

185

1.83

1.62

14.8

6.7

—

(40768443) Skin Pathology biopsy report

3.17

1.61

1.0

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.02

1.60

4.5

2.7

1.20

1.89

e6/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

222

1.78

1.57

5.0

3.2

—

(4024509) Urine culture

2.75

1.55

1.7

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

3.49

1.55

3.0

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

197

1.78

1.52

3.7

2.0

125.69

164.68

u/l

0.63

189

(3005719) IgG [Mass/volume] in Serum or Plasma

2.26

1.47

7.5

1.7

9.75

9.82

g/l

0.02

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

106

1.92

1.46

3.9

2.4

0.75

1.32

e6/l

0.58

(3002582) Erythrocytes [#/volume] in Urine

208

1.74

1.46

4.0

2.9

83.46

54.18

e6/l

0.21

155

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.08

1.38

1.2

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

259

1.67

1.31

2.3

2.4

—

estimate

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

103

1.84

1.26

1.6

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

252

1.65

1.26

2.4

2.1

93.82

101.06

pmol/l

0.47

123

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

319

1.64

1.25

9.5

8.3

1.22

1.21

mmol/l

0.12

266

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.86

1.18

1.3

1.6

—

(3023368) Bacteria identified in Blood by Culture

165

1.67

1.17

5.0

3.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

403

1.64

1.16

3.1

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.07

1.12

2.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.31

1.11

1.7

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

176

1.63

1.11

4.1

2.9

0.24

0.69

e6/l

0.86

125

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2.48

1.11

2.0

1.2

28.40

39.95

nmol/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.79

1.07

3.1

1.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.36

1.05

1.2

1.5

—

(3042936) Bacteria identified in Isolate by Culture

1.81

0.99

1.9

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

190

1.57

0.98

2.7

2.8

0.00

0.02

estimate

—

(3022145) Colonoscopy Study observation

1.82

0.95

1.3

1.4

—

(3018095) Leukocytes [#/volume] in Urine

238

1.52

0.93

4.8

3.5

10.94

250.12

e6/l

0.93

161

(3013512) EKG study

202

1.53

0.91

4.6

3.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.02

0.86

2.3

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.75

0.82

1.5

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.75

0.82

2.0

11.4

1.24

1.44

mmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.89

0.81

3.2

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.79

0.0

1.6

—

279.35

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.76

0.78

1.3

1.7

—

(3000494) Fungus identified in Specimen by Culture

1.73

0.77

2.1

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.69

0.69

1.7

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.62

0.67

1.2

1.7

—

(40761535) Cells panel - Urine sediment

1.67

0.64

5.1

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.62

0.63

1.8

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

402

1.38

0.62

5.3

4.1

—

33.60

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.00

0.61

0.0

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.83

0.60

2.2

1.5

15.92

23.51

iu/l

—

(40768804) Tissue Pathology biopsy report

258

1.35

0.55

1.8

2.1

—

(3012516) Albumin [Mass/volume] in Urine

212

1.35

0.52

3.5

3.3

208.56

54.97

mg/l

0.48

131

(40761511) CBC panel - Blood by Automated count

660

1.67

0.49

19.3

12.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.60

0.49

1.0

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.50

0.49

1.2

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

647

1.63

0.46

25.5

16.9

3.97

3.96

mmol/l

0.12

636

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.66

0.44

2.4

15.7

0.36

0.73

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.46

0.43

2.3

2.7

4.36

6.19

umol/l

0.87

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

133

1.36

0.43

2.2

2.0

—

(1002224) Polysomnography panel

1.55

0.42

1.2

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

143

1.34

0.42

2.4

1.5

1.85

2.55

g/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.41

0.0

2.8

—

148.83

—

(3024928) Oxygen saturation in Venous blood

0.00

0.41

0.0

3.4

—

64.15

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.50

0.41

1.4

1.6

—

(3003396) Base excess in Arterial blood by calculation

1.44

0.41

2.9

11.3

-2.42

1.22

mmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.41

0.40

2.3

2.1

3.92

3.33

ratio

—

(3019060) Gas panel - Arterial blood

1.46

0.40

2.6

5.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.45

0.39

1.9

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.42

0.39

2.6

13.4

24.16

24.46

mmol/l

—

(3002256) Pathology report gross observation

0.65

0.35

1.0

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

216

1.24

0.31

5.0

4.1

39.49

8.93

mg/mmol

0.60

130

(40768797) Stomach Pathology biopsy report

1.33

0.28

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

182

1.21

0.25

2.2

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

646

1.39

0.24

25.7

16.7

139.37

139.77

mmol/l

0.68

635

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.20

0.22

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.8

—

17.64

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.21

0.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.21

0.0

1.2

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.21

0.0

1.0

—

(3003694) ABO and Rh group [Type] in Blood

175

1.20

0.21

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.8

—

67.74

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.20

0.0

1.1

—

(3000492) Spirometry study

1.21

0.18

4.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.16

0.18

3.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.70

0.17

1.0

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.20

0.17

8.0

6.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.11

0.15

2.9

9.8

101.33

104.35

mmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

143

1.15

0.13

3.9

5.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

469

0.90

0.12

4.1

3.0

47.80

45.69

u/l

0.08

447

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

222

1.12

0.12

2.8

2.3

58.63

94.86

u/l

0.68

203

(3026008) Bacteria identified in Urine by Culture

174

1.12

0.11

3.4

3.0

—

(3000991) Gas panel - Venous blood

1.15

0.10

3.4

12.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.07

0.09

1.2

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.06

0.09

2.0

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1.08

0.08

2.3

112.29

31.48

u/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

138

1.11

0.07

4.5

4.7

23.79

21.01

—

(3029937) Albumin [Presence] in Urine by Test strip

190

1.07

0.04

4.3

3.3

0.00

estimate

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.09

0.02

1.9

1.4

—

(1761868) Lipid panel - Serum or Plasma

263

1.04

0.01

3.2

3.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

528

1.01

0.00

29.5

17.8

13.47

13.60

0.38

522

(3012095) Magnesium [Moles/volume] in Serum or Plasma

115

1.05

0.00

4.3

3.5

0.82

mmol/l

0.01

115

(46235355) HIV 1 and 2 tests - Meaningful Use set

114

0.96

0.00

1.4

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

4.9

—

0.57

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

6.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.02

-0.00

1.2

2.6

2.94

5.54

ug/l

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

1.6

—

15.04

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.0

—

9.07

—

(4035726) Immunohistochemistry procedure

0.96

-0.00

1.3

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

82.40

—

(21494755) Public health laboratory ask at order entry panel

1.01

-0.00

1.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

2.7

—

31.83

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

2.6

—

12.57

—

(3012544) pH of Venous blood

0.85

-0.00

3.0

4.5

7.38

7.39

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

17.9

—

1019.44

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(4062490) Immunoglobulin typing, IgG

0.00

-0.00

0.0

1.5

—

(40761536) Microorganisms panel - Urine sediment

0.89

-0.00

4.2

3.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

8.54

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.8

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

2.6

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

2.6

—

0.86

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

2.4

—

67.46

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

12.29

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

-0.00

0.0

1.9

—

13.71

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

154.07

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

18.48

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OTERSPECARTHR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_OTERSPECARTHR.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_OTERSPECARTHR – Other specific arthropathies

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specific arthropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints